Team SAINT

Team SAINT proposes a structurally unique nanoparticle drug-conjugate system that can target and eliminate virtually any oncological target by using a liposome embedded with cytotoxic drugs and antibodies. By utilizing microfluidic devices, Team SAINT will be able to produce a manufacturing process that can output generalized nanomedicines given any cytotoxic drug and the necessary binders. These drugs can be tailored for any specified cancer cells and their respective receptors.